Charles W. Stark - 23 Nov 2021 Form 3 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
SVP, Clinical Development
Signature
Charles W. Stark
Issuer symbol
EMMA
Transactions as of
23 Nov 2021
Net transactions value
$0
Form type
3
Filing time
28 Dec 2021, 18:37:58 UTC
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EMMA Common stock, $0.001 par value 3,480 23 Nov 2021 Direct
holding EMMA Common stock, $0.001 par value 14,702 23 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EMMA Stock Option 23 Nov 2021 Common Stock 105,014 $3.43 Direct
holding EMMA Stock Option 23 Nov 2021 Common Stock 105,014 $4.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown are owned jointly with Kimxa Stark, the reporting person's wife.